# Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery

> **NCT04773093** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 50 (estimated)

## Conditions studied

- Craniotomy Tumor Removal Surgery

## Interventions

- **DRUG:** Continous Intravenous Lidocaine Infusion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04773093
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04773093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04773093, "Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04773093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*